OTHER SOLID TUMORS
Clinical trials for OTHER SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new OTHER SOLID TUMORS trials appear
Sign up with your email to follow new studies for OTHER SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-stage study tests an experimental drug called SGN-MesoC2 in 19 adults with advanced solid tumors (like lung, ovarian, or pancreatic cancer) that have not responded to standard treatments. The drug is designed to stick to cancer cells and kill them. The main goals are t…
Matched conditions: OTHER SOLID TUMORS
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 17, 2026 00:32 UTC
-
New drug candidate BL-B01D1 enters early human testing for tough cancers
Disease control OngoingThis early-phase study tests a new drug called BL-B01D1 in people with advanced urinary or other solid tumors that cannot be cured or have no standard treatments. The main goals are to check safety, find the right dose, and see if the drug shrinks tumors. Only 4 participants are …
Matched conditions: OTHER SOLID TUMORS
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 00:29 UTC